Broad-spectrum vaccines: making pandemics obsolete

In the last century, vaccines have significantly reduced and even eradicated historically pervasive pathogens. However, rapidly mutating or naturally polymorphic pathogens such as HIV, influenza, coronaviruses, dengue, and Zika continue to challenge vaccine science. Our patented breakthrough epitope-focusing technology guides the immune response against conserved parts of pathogens that cannot mutate. Our broad-spectrum Centivax flu vaccine is supported by the Bill and Melinda Gates Foundation “Grand Challenge: Ending the Pandemic Threat” and is featured on Netflix in Pandemic: How to Prevent an Outbreak.